UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells

Pharmaceutical research, 2015-03, Vol.32 (3), p.779-792

2015

Volltextzugriff (PDF)

Improving Paclitaxel Delivery: In Vitro and In Vivo Characterization of PEGylated Polyphosphoester-Based Nanocarriers

Journal of the American Chemical Society, 2015-02, Vol.137 (5), p.2056-2066

2015

Volltextzugriff (PDF)

UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors

Cancer, 2013-02, Vol.119 (4), p.915-923

2013

Volltextzugriff (PDF)

Strategies for the targeted delivery of therapeutics for osteosarcoma

Expert opinion on drug delivery, 2009-12, Vol.6 (12), p.1311-1321

Hughes, Dennis PM

2009

Volltextzugriff (PDF)

Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo

Cancer, 2010-07, Vol.116 (13), p.3233-3243

2010

Volltextzugriff (PDF)

How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize

Cancer treatment and research, 2009, Vol.152, p.479

Hughes, Dennis P M

2009

Volltextzugriff (PDF)

Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy

Paediatric drugs, 2015-08, Vol.17 (4), p.257-271

2015

Volltextzugriff (PDF)

Correction to “Improving Paclitaxel Delivery: In Vitro and In Vivo Characterization of PEGylated Polyphosphoester-Based Nanocarriers”

Journal of the American Chemical Society, 2015-06, Vol.137 (21), p.6972-6972

2015

Volltextzugriff (PDF)

Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression

Frontiers in oncology, 2013-01, Vol.3, p.230-230

2013

Volltextzugriff (PDF)

Slow Down to Stay Alive: HER4 Protects Against Cellular Stress and Confers Chemoresistance in Neuroblastoma

Cancer, 2012-10, Vol.118 (20), p.5140-5154

2012

Volltextzugriff (PDF)

Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (6), p.2047-2053

2004

Volltextzugriff (PDF)

Cetuximab Attenuates Metastasis and u-PAR Expression in Non-Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (6), p.2461-2470

2009

Volltextzugriff (PDF)

Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis

Clinical cancer research, 2008-05, Vol.14 (10), p.2962-2969

2008

Volltextzugriff (PDF)

Novel agents in development for pediatric sarcomas

Current opinion in oncology, 2009-07, Vol.21 (4), p.332-337

Hughes, Dennis PM

2009

Volltextzugriff (PDF)

New, tolerable γ-secretase inhibitor takes desmoid down a notch

Clinical cancer research, 2015-01, Vol.21 (1), p.7-9

2015

Volltextzugriff (PDF)

Developmental pathways hijacked by osteosarcoma

Advances in experimental medicine and biology, 2014, Vol.804, p.93

2014

Volltextzugriff (PDF)

Understanding the role of Notch in osteosarcoma

Advances in experimental medicine and biology, 2014, Vol.804, p.67

2014

Volltextzugriff (PDF)

Ex vivo culture with interleukin (IL)-12 improves CD8+ T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-γ but requires perforin

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4913-4921

2006

Volltextzugriff (PDF)

Slow down to stay alive

Cancer, 2012-10, Vol.118 (20), p.5140-5154

2012

Volltextzugriff (PDF)

Complications in the surgical treatment of pediatric melanoma

Journal of pediatric surgery, 2013-06, Vol.48 (6), p.1249-1253

2013

Volltextzugriff (PDF)

Critical signaling pathways in bone sarcoma: Candidates for therapeutic interventions

Current oncology reports, 2009-11, Vol.11 (6), p.446-453

2009

Volltextzugriff (PDF)

Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness

Oncogene, 2010-05, Vol.29 (20), p.2916-2926

2010

Volltextzugriff (PDF)

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition

Pediatric Blood & Cancer, 2006-05, Vol.46 (5), p.614-623

2006

Volltextzugriff (PDF)

Primary tuberculosis of bone mimicking a lytic bone tumor

Journal of pediatric hematology/oncology, 2007-03, Vol.29 (3), p.198-202

2007

Volltextzugriff (PDF)

Driven to Death: Inhibition of Farnesylation Increases Ras Activity in Osteosarcoma and Promotes Growth Arrest and Cell Death

Molecular cancer therapeutics, 2010-05, Vol.9 (5), p.1111-1119

2010

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(126)
Japanisch
(22)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(7)
Cancer
(4)
Clinical Cancer Research
(4)
Bioscience
(3)
Political Studies
(3)
Advances In Experimental Medicine And Biology
(2)
Blood
(2)
Bmj
(2)
Bmj. British Medical Journal
(2)
Current Advances In Osteosarcoma
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells

Improving Paclitaxel Delivery: In Vitro and In Vivo Characterization of PEGylated Polyphosphoester-Based Nanocarriers

UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors

Strategies for the targeted delivery of therapeutics for osteosarcoma

Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo

How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize

Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy

Correction to “Improving Paclitaxel Delivery: In Vitro and In Vivo Characterization of PEGylated Polyphosphoester-Based Nanocarriers”

Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression

Slow Down to Stay Alive: HER4 Protects Against Cellular Stress and Confers Chemoresistance in Neuroblastoma

Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma

Cetuximab Attenuates Metastasis and u-PAR Expression in Non-Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity

Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis

Novel agents in development for pediatric sarcomas

New, tolerable γ-secretase inhibitor takes desmoid down a notch

Developmental pathways hijacked by osteosarcoma

Understanding the role of Notch in osteosarcoma

Ex vivo culture with interleukin (IL)-12 improves CD8+ T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-γ but requires perforin

Slow down to stay alive

Complications in the surgical treatment of pediatric melanoma

Critical signaling pathways in bone sarcoma: Candidates for therapeutic interventions

Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition

Primary tuberculosis of bone mimicking a lytic bone tumor

Driven to Death: Inhibition of Farnesylation Increases Ras Activity in Osteosarcoma and Promotes Growth Arrest and Cell Death

Suchergebnisse filtern